Annual report [Section 13 and 15(d), not S-K Item 405]

Stock-Based Compensation

v3.26.1
Stock-Based Compensation
12 Months Ended
Dec. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

10. Stock-Based Compensation

A summary of our various equity incentive plans is set forth below:

2023 and 2022 Inducement Plans

In 2023, our board of directors adopted three inducement plans; the Phunware, Inc. 2023B Inducement Plan, the Phunware, Inc. 2023 Inducement Plan and the Phunware, Inc. 2022 Inducement Plan (collectively, the "Inducement Plans"). As permitted by Nasdaq Stock Market rules, our stockholders were not required to approve the Inducement Plans. The plans collectively provide of up to 53,412 shares of our common stock under awards granted to newly hired employees. An "award" is any right to receive common stock of the Company consisting of nonstatutory stock options, stock appreciation rights, restricted stock awards or restricted stock units. Shares will be delivered electronically to the holder shortly after exercise or vest date pursuant to an effective registration statement.

2018 Equity Incentive Plan

In 2018, our board of directors adopted, and our stockholders approved, the 2018 Equity Incentive Plan, as amended (the “2018 Plan”). The purposes of the 2018 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentives to employees, directors and consultants who perform services for the Company, and to promote the success of our business. These incentives are provided through the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares. Shares will be delivered electronically to the holder shortly after exercise or vest date pursuant to an effective registration statement.

The number of shares of common stock available for issuance under the 2018 Plan will also include an annual increase on the first day of each fiscal year, equal to the lesser of 5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year or such other amount as our board of directors may determine.

2018 Employee Stock Purchase Plan

Also, in 2018, our board of directors adopted, and our stockholders approved, the 2018 Employee Stock Purchase Plan (the “2018 ESPP”). The purpose of the 2018 ESPP is to provide eligible employees with an opportunity to purchase shares of our common stock at a discount through accumulated contributions generally in the form of payroll deductions of up to 15% of eligible compensation, subject to caps of $25,000 in any calendar year and 80 shares on any purchase date. The 2018 ESPP provides for 24-month offering periods, generally beginning in June and December of each year, and each offering period consists of four six-month

purchase periods. The first purchase under the 2018 ESPP was in December 2021. Participation ends automatically upon termination of employment with the Company.

On each purchase date, participating employees will purchase shares of our common stock at price per share equal to 85% of the lesser of the fair market value of our common stock on (i) the first trading day of the applicable offering period and (ii) the last trading day of each purchase period in the applicable offering period. If the price per share of our common stock on any purchase date in the offering period is lower than the stock price on the enrollment date of that offering period, the offering period will immediately reset after the purchase of shares on such purchase date and automatically roll into a new offering period. Shares will be delivered electronically to the participant shortly after the purchase date pursuant to an effective registration statement.

We use a Black-Scholes option pricing model to determine the fair value of shares to be purchased under the 2018 ESPP.

The number of shares of common stock that may be made available for sale under the 2018 ESPP also includes an annual increase on the first day of each fiscal year beginning for the fiscal year following the fiscal year in which the first enrollment date (if any) occurs equal to the lesser of (i) 16,377 shares of common stock; (ii) 1.5% of the outstanding shares of common stock on the last day of the immediately preceding fiscal year; or such other amount as the administrator may determine. The 2018 ESPP had 63,167 and 46,791 shares of common stock available for sale and reserved for issuance as of December 31, 2025 and 2024, respectively.

2009 Equity Incentive Plan

In 2009, we adopted the 2009 Equity Incentive Plan (the "2009 Plan"), which allowed for the granting of incentive and non-statutory stock options, as defined by the Internal Revenue Code, to employees, directors and consultants. The exercise price of the options granted was generally equal to the value of our common stock on the date of grant, as determined by our board of directors. The awards are exercisable and vested, generally over four years, in accordance with each option agreement. The term of each option is no more than ten years from the date of the grant. The 2009 Plan allowed for options to be immediately exercisable, subject to the Company’s right of repurchase for unvested shares at the original exercise price. There were no unvested shares subject to repurchase provisions outstanding as of December 31, 2025 and 2024. Upon exercise, shares will be delivered electronically to the holder pursuant to an effective registration statement. Effective with the adoption of the 2018 Plan, no additional grants will be made under the 2009 Plan.

Additional Disclosures

Our stock benefit plans had 1,232,912 and 220,006 shares of common stock reserved for future issuances under our equity incentive plans as of December 31, 2025 and December 31, 2024, respectively. In addition, the shares of common stock reserved for issuance under the 2018 Plan also will include any shares of common stock subject to stock options, restricted stock units or similar awards granted under the 2009 Plan, that, on or after the adoption of the 2018 Plan, expire or otherwise terminate without having been exercised in full and shares of common stock issued pursuant to awards granted under the 2009 Plan that are forfeited. As of December 31, 2025, the maximum number of shares of common stock that may be added to the 2018 Plan pursuant to the foregoing is 883.

Restricted Stock Units

A summary of our restricted stock unit activity is set forth below:
 

 

Shares

 

 

Weighted Average Grant Date Fair Value

 

Outstanding as of December 31, 2024

 

 

38,420

 

 

$

23.01

 

Granted

 

 

-

 

 

 

-

 

Released

 

 

(17,415

)

 

 

26.48

 

Forfeited

 

 

(3,273

)

 

 

14.43

 

Outstanding as of December 31, 2025

 

 

17,732

 

 

$

21.17

 

 

During 2024, we granted 84,089 restricted stock units to board members and external consultants with an average grant date fair value of $5.63. Each of the restricted stock unit grants vested immediately. The restricted stock unit grants were valued based on the fair value of our common stock on the date of grant.

Stock Options

A summary of our stock option activity under the 2018 Plan and related information is as follows:
 

 

Number of Shares

 

 

Weighted Average
Exercise Price

 

 

Weighted Average
Remaining
Contractual Term
(years)

 

 

Aggregate Intrinsic
Value

 

Outstanding as of December 31, 2024

 

 

2,500

 

 

$

56.89

 

 

 

3.19

 

 

$

-

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Cancelled/Expired

 

 

(1,500

)

 

 

38.15

 

 

 

 

 

 

 

Outstanding and exercisable as of December 31, 2025

 

 

1,000

 

 

$

85.00

 

 

 

6.61

 

 

$

-

 

 

A summary of our stock option activity under the 2009 Plan and related information is set forth below:
 

 

Number of Shares

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining
Contractual Term (years)

 

 

Aggregate Intrinsic Value

 

Outstanding as of December 31, 2024

 

 

1,190

 

 

$

91.61

 

 

 

2.50

 

 

$

-

 

Granted

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Exercised

 

 

-

 

 

 

-

 

 

 

 

 

 

 

Cancelled/Expired

 

 

(307

)

 

 

28.48

 

 

 

 

 

 

 

Outstanding and exercisable as of December 31, 2025

 

 

883

 

 

$

113.56

 

 

 

2.24

 

 

$

-

 

We have historically used the Black-Scholes option pricing model to estimate the fair value of our stock option awards.

Stock-Based Compensation

Compensation cost that has been included in our consolidated statements of operations and comprehensive loss for all stock-based compensation arrangements is set forth below:
 

 

Year ended December 31,

 

(in thousands)

 

2025

 

 

2024

 

Cost of revenues

 

$

62

 

 

$

179

 

Sales and marketing

 

 

34

 

 

 

65

 

General and administrative

 

 

351

 

 

 

1,341

 

Research and development

 

 

8

 

 

 

71

 

Total stock-based compensation

 

$

455

 

 

$

1,656

 

 

As of December 31, 2025, there was approximately $0.2 million total unrecognized compensation cost related to our stock benefit plans. These unrecognized compensation costs are expected to be recognized over an estimated weighted-average period of approximately 0.56 years.